Answer ALS: Individualized Initiative for ALS Discovery

CompletedOBSERVATIONAL
Enrollment

1,049

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

January 1, 2020

Conditions
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALSProgressive Muscular AtrophyMonomelic AmyotrophyMotor Neuron DiseaseAsymptomatic ALS Gene CarriersHealthy Controls
Trial Locations (8)

21205

Johns Hopkins University, Baltimore

30322

Emory University, Atlanta

43221

Ohio State University Wexner Medical Center, Columbus

60611

Northwestern University Feinberg School of Medicine, Chicago

63110

Washington University School of Medicine, St Louis

75214

Texas Neurology, Dallas

90048

Cedars-Sinai Medical Center, Los Angeles

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Emory University

OTHER

collaborator

Ohio State University

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

University of California, Irvine

OTHER

collaborator

Massachusetts Institute of Technology

OTHER

collaborator

New York Genome Center

OTHER

collaborator

Leandro P. Rizzuto Foundation

OTHER

collaborator

Texas Neurology

UNKNOWN

collaborator

Northwestern University Les Turner ALS Center

UNKNOWN

lead

Johns Hopkins University

OTHER

NCT02574390 - Answer ALS: Individualized Initiative for ALS Discovery | Biotech Hunter | Biotech Hunter